The clinical features of this disease appear to be due—at least in part—to the production of a superantigen—YpM (
Yersinia pseudotuberculosis-derived mitogen). This is present in almost all strains from the Far East but only 20% of European isolates. The antigen was discovered in 1993 and is encoded by a 456-base gene. The protein has 151 amino acids, with a signal sequence of 20 amino acids. The mitogenic antigens are scattered across the protein but two
cysteine residues (residues 32 and 129) which form a disulfide bridge are critical. The
G+C content of this gene is 35%—lower than the genomic average (47%) suggesting that this gene has been acquired from some other organism. The organism from which this gene originated has not yet been identified. This gene seems likely to have been introduced into the genome by a
bacteriophage, given the nearby presence of a phage integration site, but the mechanism of entry into the genome is not currently known. ==Diagnosis==